Figure 2
From: Safety, pharmacokinetics, and pharmacodynamics of milvexian in healthy Japanese participants
Mean (± SD) aPTT profile over time on (a) Day 1 and (b) Day 14. SD, standard deviation; aPTT, activated partial thromboplastin time. Milvexian 50 mg and 200 mg were administered under fasted conditions. Milvexian 500 mg was administered under fed conditions.
